Indian drug for dementia gets US regulatory nod
In a regultory filing on the BSE, the city-based company said the US Food & Drug Administration (USFDA) has approved its 5mg and 10mg Memantine Hydrochloride tablets for treating moderate to severe Alzheimer`s-type dementia.
May 24, 2017, 19:20 PM IST